National Resilience acquired the Triangle office in 2021. Since then, funding for gene therapy solutions has fallen.

Viralgen and two labs based in the Broad Institute of MIT (Massachusetts Institute of Technology) and Harvard University have ...

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

Gene therapy firm Capsida Biotherapeutics is advancing the first of its AbbVie-partnered neurodegenerative disease therapies ...

In a finding with implications for one of the most promising cutting-edge medical treatments, researchers evaluated several ...

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

Part B of the LIGHTHOUSE study will enroll adults and children. DURHAM, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

One drive is the rising prevalence of chronic diseases like cancer and diabetes. Increased investment in research and development is accelerating the discovery and refinement of cell and gene ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

A new study published in the peer-reviewed journal Human Gene Therapy involved the generation of a human monoclonal antibody ...